Lincoln Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

291.61

264.08

222.42

245.38

223.32

Operating profit

51.86

45.82

40.89

52.17

48.24

Interest

0.81

0.55

0.87

0.58

0.54

Gross profit

67.44

57.45

44.54

57.68

50.89

EPS (Rs)

23.30

19.33

14.29

20.13

17.59

Other income

16.39

12.18

4.53

6.09

3.19

Stock adjustment

9.91

-4.31

-11.67

-1.84

6.18

Raw material

92.36

95.29

83.67

60.07

47.49

Power and fuel

-

-

-

-

-

Employee expenses

51.41

45.98

34.35

30.21

24.72

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

86.06

81.30

75.19

104.77

96.70

Provisions made

-

-

-

-

-

Depreciation

5.13

4.49

4.18

2.95

2.83

Taxation

15.65

14.23

11.74

14.47

12.88

Net profit / loss

46.67

38.72

28.63

40.26

35.19

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

20.03

20.03

20.03

20.00

20.00

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

17.79

17.35

18.38

21.26

21.60

GPM (%)

21.90

20.80

19.63

22.94

22.47

NPM (%)

15.15

14.02

12.61

16.01

15.53